Global Digital Polymerase Chain Reaction (PCR) Market, By Technology (Droplet Digital PCR (ddPCR), Beaming Digital PCR), Product Type (Digital PCR Equipment, Consumables and Reagents, Software and Services), Application (Clinical, Oncology Testing, Blood Screening, Transplant Diagnostics, Research), End User (Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Forensic Laboratories, Pharmaceutical and Biotechnology Companies) – Industry Trends and Forecast to 2030.
Digital Polymerase Chain Reaction (PCR) Market Analysis and Size
A significant decline in industry growth is expected to reduce demand for diagnostic tests for COVID-19 infection during the forecast period. However, some key factors, such as the increasing use of polymerase chain reaction (PCR) in research and forensic laboratories and the growing demand for advanced diagnostics. Furthermore, the introduction of new technologies and an increase in the number of contract research organisations are expected to drive PCR test demand forward during the forecast period.
Data Bridge Market Research analyses that the digital polymerase chain reaction (PCR) market which was USD 0.75 billion in 2022, is expected to reach USD 1.49 billion by 2030, at a CAGR of 9.0% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Digital Polymerase Chain Reaction (PCR) Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Technology (Droplet Digital PCR (ddPCR), Beaming Digital PCR), Product Type (Digital PCR Equipment, Consumables and Reagents, Software and Services), Application (Clinical, Oncology Testing, Blood Screening, Transplant Diagnostics, Research), End User (Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Forensic Laboratories, Pharmaceutical and Biotechnology Companies)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Agilent Technologies, Inc. (U.S.), bioMérieux (France), Merck KGaA (Germany), Standard BioTools (U.S.), Takara Bio Inc. (Japan), Beckman Coulter, Inc. (U.S.), BD (U.S.), Cepheid. (U.S.), Eppendorf SE (Germany), General Electric (U.S.), Roche Sequencing (U.S.), PerkinElmer Inc. (U.S.), Promega Corporation (U.S.), Siemens (Germany), Danaher (U.S.). QIAGEN (Germany)
|
|
Market Opportunities
|
|
Market Definition
Global Digital Polymerase Chain Reaction (PCR) Market Dynamics
Drivers
- Rising frequency of infectious diseases
The polymerase chain reaction (PCR) has been used and shown to be effective in detecting minute amounts of a wide range of infectious agents. The best conditions for amplification vary depending on the organisms of interest. PCR was used as a rapid and sensitive method for detecting infectious agents, and three assay systems were developed, one for amplifying human T cell leukaemia virus type I, one for Mycobacterium tuberculosis, and one for Mycoplasma pneumoniae. These all factors will propel the market.
Furthermore, the ageing population and the rising frequency of infectious diseases significantly impact the growth of the real-time polymerase chain reaction technology market.
- Rising research and development activities
The increased use of the polymerase chain reaction for cancer diagnosis is expected to drive market growth. All of these factors are responsible for creating a greater demand for this technique, research and development activities for providing innovative molecular biology and forensic science as there has high demand for genetic engineering as well as personalized medicines the market is expected to grow well during the forecast period.
Opportunities
- Rising demand for polymerase chain reaction
The majority of the market opportunities are due to increasing demand for personalized medicines. Technology that can gather information at the molecular level to detect a disease will be extremely useful. Polymerized chain reaction techniques are widely used in all screening methods. The introduction of the polymerase chain reaction boosted the biotechnology industry. Polymerase chain reaction is a vital component of both the life sciences and the pharmaceutical industry. As the devices are used on a large scale for drug discovery, the demand for polymerase chain reaction technology is expected to increase significantly in the coming years.
Restraints/Challenges
- High cost of technology
The technical limitations and high cost of technology will obstruct the market's growth rate.
High device costs associated with d-PCR and technical limitations of q-PCR and d-PCR techniques may impede the growth of the digital PCR market growth during the forecast period. In contrast, high adoption and implementation of MIQE guidelines is the most significant challenge to the growth of the digital polymerase chain reaction (PCR) market.
This digital polymerase chain reaction (PCR) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the digital polymerase chain reaction (PCR) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Digital Polymerase Chain Reaction (PCR) Market
The digital polymerase chain reaction (PCR) market currently consists of kits, assays, systems, reagents, and consumables. The unexpected pandemic crisis has increased demand for essentials and increased demand for digital PCR products. Biotechnology and life sciences companies have increased their demand for digital PCR. COVID-19 has had a low-moderate impact on the global d-PCR market size. Some market participants have reported a slight decrease in sales. However, some new entrants in the global d-PCR market are expected to see market growth. Revenues are also down, owing primarily to the initial stages of the COVID-19 pandemic, which included complete lockdowns across countries and major cities, disrupting the supply chain. Several other products have been in the works for years and may take longer than 2-4 years to commercialize. The pandemic has significantly improved the growth prospects of digital PCR-based diagnostics and is expected to indirectly improve the market growth outlook.
Recent Developments
- In March 2022, Stilla signed an agreement with 12 distributors across EMEA. Stilla's entire product portfolio, including the six-color naica system, is covered by this agreement.
- In April 2022, Stilla and Promega Corporation signed a co-marketing agreement to offer a complete digital PCR workflow solution to their end users, including liquid biopsy, sentinel pathogen testing, infectious disease assay, overall cancer research, and drug discovery.
- In October 2021, Dropworks, Inc., a development stage company focused on developing a digital PCR product, was acquired by Bio-Rad Laboratories, Inc. The company's life sciences product offerings would be expanded and supplemented as part of the strategy.
Global Digital Polymerase Chain Reaction (PCR) Market Scope
The digital polymerase chain reaction (PCR) market is segmented on the basis of technology, product type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Droplet Digital PCR (ddPCR)
- Beaming Digital PCR
Product Type
- Digital PCR Equipment
- Consumables and Reagents
- Software and Services
Application
- Clinical
- Oncology Testing
- Blood Screening
- Transplant Diagnostics
- Research
End User
- Hospitals and Diagnostic Centers
- Research Laboratories and Academic Institutes
- Forensic Laboratories
- Pharmaceutical and Biotechnology Companies
Digital Polymerase Chain Reaction (PCR) Market Regional Analysis/Insights
The digital polymerase chain reaction (PCR) market is analyzed and market size insights and trends are provided by country, technology, product type, application and end user as referenced above.
The countries covered in the digital polymerase chain reaction (PCR) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the digital polymerase chain reaction (PCR) market owing to the rising technological advancements, higher expenses on research and development, and enhanced healthcare infrastructure in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the high adoption of digital PCR method for counting nucleic acid amounts in this particular region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The digital polymerase chain reaction (PCR) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital polymerase chain reaction (PCR) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the digital polymerase chain reaction (PCR) market. The data is available for historic period 2011-2021.
Competitive Landscape and Digital Polymerase Chain Reaction (PCR) Market Share Analysis
The digital polymerase chain reaction (PCR) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to digital polymerase chain reaction (PCR) market.
Some of the major players operating in the digital polymerase chain reaction (PCR) market are:
- Thermo Fisher Scientific Inc. (U.S.)
- Bio-Rad Laboratories Inc. (U.S.)
- Agilent Technologies, Inc. (U.S.)
- bioMérieux (France)
- Merck KGaA (Germany)
- Standard BioTools (U.S.)
- Takara Bio Inc. (Japan)
- Beckman Coulter, Inc. (U.S.)
- BD (U.S.)
- Cepheid. (U.S.)
- Eppendorf SE (Germany)
- General electric (U.S.)
- Roche Sequencing (U.S.)
- PerkinElmer Inc. (U.S.)
- Promega Corporation (U.S.)
- Siemens (Germany)
- Danaher (U.S.)
- QIAGEN (Germany)
Research Methodology: Global Digital Polymerase Chain Reaction (PCR) Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.
SKU-
